SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

Soleus Capital Management, L.P.'s Holding History (CIK: 0001802630)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,247,110 Value ($000) $47,212 Avg Close $17.45 Range $12.99 - $22.73
Q3 2025
Shares 2,012,110 Value ($000) $30,956 Avg Close $13.09 Range $8.59 - $17.24
Q2 2025
Shares 1,092,110 Value ($000) $10,228 Avg Close $11.01 Range $8.58 - $14.24
Q1 2025
Shares 816,610 Value ($000) $10,032 Avg Close $14.10 Range $12.06 - $16.95
Q4 2024
Shares 2,492,000 Value ($000) $32,944 Avg Close $17.11 Range $12.40 - $22.50
Q3 2024
Shares 1,090,984 Value ($000) $21,001 Avg Close $20.66 Range $17.34 - $25.07
Q2 2024
Shares 826,500 Value ($000) $16,968 Avg Close $20.93 Range $18.65 - $24.38
Q1 2024
Shares 369,000 Value ($000) $8,782 Avg Close $22.30 Range $19.58 - $25.34
Q4 2023
Shares 514,000 Value ($000) $11,108 Avg Close $15.37 Range $11.21 - $21.84
Q3 2023
Shares 119,500 Value ($000) $1,735 Avg Close $18.92 Range $12.85 - $23.55
Q2 2023
Shares 212,600 Value ($000) $4,450 Avg Close $20.82 Range $19.27 - $23.14
Q1 2023
Shares 322,600 Value ($000) $6,813 Avg Close $24.88 Range $20.01 - $29.86
Q4 2022
Shares 220,000 Value ($000) $5,599 Avg Close $23.32 Range $20.25 - $26.51
Q1 2020
Shares 20,980 Value ($000) $230 Avg Close $9.38 Range $6.32 - $12.27
Q4 2019
Shares 20,980 Value ($000) $184 Avg Close $7.34 Range $5.35 - $9.47